BFRI
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.61
+6.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 7.75x
- P/E 2028E
- 8.16x
- P/S forward
- 0.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.01x
- Price / sales
- 0.52x
- Price / cash flow
- -3.02x
Enterprise value
- Enterprise value
- $26.7M
- EV / sales
- 0.58x
- EV / EBITDA
- -4.75x
- EV / EBIT
- -6.13x
- Market cap
- $23.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026